Question 1

Does Citadel Advisors own NEUP stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 72,559 shares of NEUP (Neuphoria Therapeutics), worth $317,083.

Question 2

How many shares of NEUP does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 72,559 shares of NEUP (Neuphoria Therapeutics).

Question 3

What is Citadel Advisors' NEUP position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' NEUP position is worth $317,083.

Question 4

Is Citadel Advisors buying or selling NEUP?

Accepted Answer

In Q2 2026, Citadel Advisors increased its NEUP position from 19,331 to 72,559 shares.

Question 5

When did Citadel Advisors first buy NEUP?

Accepted Answer

Citadel Advisors first reported NEUP in its Q2 2025 13F and has listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	72,559	+275.4%	$317,083	0.0%	$4.37	26
2026-Q1	New	19,331	-	$78,677	0.0%	$4.07	33
2025-Q3	Exited	0	-100.0%	$0	0.0%	$11.79	0
2025-Q2	New	14,606	-	$103,703	0.0%	$7.10	33

NEUP4 quarters

NEUP
4 quarters